SCHEMBL4331795

SCHEMBL4331795

CC(C)Oc1ccc(N(C)C(=O)C2c3ccccc3C(=O)N2C2CNC2)cn1

nearest known ligand 0.35

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.35
SCN9A Q15858 4/20 0.34
FPR1 P21462 2/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
TSHR P16473 1/20 0.34
FFAR2 O15552 1/20 0.33
OXTR P30559 4/20 0.33
AVPR1A P37288 2/20 0.33
KCNH2 Q12809 3/20 0.33
CHRNA7 P36544 2/20 0.33
SCN5A Q14524 2/20 0.33
HTR2A P28223 2/20 0.32
HTR2C P28335 2/20 0.32
HTR2B P41595 2/20 0.32
KCNA5 P22460 1/20 0.32
ALDH1A1 P00352 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4321206 0.76 SCN9A (0.41) SCN9AOXTRAVPR1AKCNH2SCN5A
SCHEMBL4334944 0.74 SCN9A (0.43) SCN9AKCNH2SCN5A
SCHEMBL4329044 0.73 NPSR1 (0.40) SMN1; SMN2SCN9AFPR1CYP1A2CYP3A4
SCHEMBL13579023 0.66 SCN9A (0.67) SMN1; SMN2SCN9AFPR1CYP1A2CYP3A4
SCHEMBL4326647 0.65 SCN9A (0.64) SMN1; SMN2SCN9AFPR1CYP1A2CYP3A4
SCHEMBL4239973 0.62 TSHR (0.45) SMN1; SMN2SCN9AFPR1CYP1A2CYP3A4
SCHEMBL4332779 0.61 SCN9A (0.58) SCN9AKCNH2SCN5A
SCHEMBL12526943 0.59 ACACB (0.38) SCN9AOXTRCHRNA7ALDH1A1
SCHEMBL14312250 0.58 HTR2B (0.44) TSHRHTR2AHTR2CHTR2BALDH1A1
SCHEMBL14312249 0.58 HTR2B (0.44) TSHRHTR2AHTR2CHTR2BALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009145720-A1 ISOINDOLINE DERIVATIVES COMPRISING ADDITIONAL HETEROCYCLIC GROUPS AND THEIR USE IN THE TREATMENT OF PAIN DISORDERS ASTRAZENECA AB (SE) 2009-12-03 WO disclosed